2022
medRxiv (2022). 10.1101/2022.07.11.22277482.
2022
Scientific Reports, (2022).12 1 10.1038/s41598-022-09037-8.
Challenges of using modelling evidence in the visceral leishmaniasis elimination programme in India.
2022
PLOS global public health, (2022).2 11 10.1371/journal.pgph.0001049.
2022
Vaccine, (2022).41 Sup, 10.1016/j.vaccine.2022.08.008.
2022
medRxiv (2022). 10.1101/2022.05.22.22275417.
2022
The Lancet. Infectious diseases, (2022).22 5 10.1016/S1473-3099(22)00001-9.
2022
Vaccines, (2022).10 11 10.3390/vaccines10111838.
2022
Advances in Biological Regulation, (2022).86, 10.1016/j.jbior.2022.100918.
2022
BMJ Open, (2022).12 7 10.1136/bmjopen-2022-061206.
2022
Frontiers in Public Health, (2022).10, 10.3389/fpubh.2022.841883.